14-day Premium Trial Subscription Try For FreeTry Free

Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of EVOK
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Big movements in Evoke Pharma stock price on Thursday moving 23.98% between high and low
(Updated on May 02, 2024)

Sell candidate since Apr 03, 2024 Loss -26.18% PDF

The Evoke Pharma stock price fell by -4.65% on the last day (Thursday, 2nd May 2024) from $0.480 to $0.458. During the last trading day the stock fluctuated 23.98% from a day low at $0.410 to a day high of $0.509. The price has fallen in 6 of the last 10 days and is down by -4.41% for this period. Volume has increased on the last day by 17 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 22 thousand shares were bought and sold for approximately $10.19 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -33.47% during the next 3 months and, with a 90% probability hold a price between $0.275 and $0.355 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

EVOK Signals & Forecast

A buy signal was issued from a pivot bottom point on Thursday, April 25, 2024, and so far it has risen 4.98%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Evoke Pharma stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $0.541. On a fall, the stock will find some support from the short-term average at $0.453. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Evoke Pharma gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Evoke Pharma stock

Evoke Pharma finds support from accumulated volume at $0.450 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.0984 between high and low, or 23.98%. For the last week, the stock has had daily average volatility of 12.56%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (EVOK) For The Upcoming Trading Day Of Friday 3rd

For the upcoming trading day on Friday, 3rd we expect Evoke Pharma to open at $0.459, and during the day (based on 14 day Average True Range), to move between $0.399 and $0.516, which gives a possible trading interval of +/-$0.0582 (+/-12.72%) up or down from last closing price. If Evoke Pharma takes out the full calculated possible swing range there will be an estimated 25.43% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.450 (1.68%) than the resistance at $0.510 (11.43%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Evoke Pharma stock A Buy?

Evoke Pharma holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -2.426 Sell Candidate Unchanged

Predicted Opening Price for Evoke Pharma of Friday, May 3, 2024

Fair opening price May 3, 2024 Current price
$0.459 ( 0.277%) $0.458

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for EVOK

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.557 21.78 %
R2 0.520 13.56 %
R1 0.497 8.49 %
Current price: 0.458
Support S1 0.421 -7.94 %
S2 0.398 -13.01 %
S3 0.361 -21.22 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.540 18.00 %
R2 0.530 15.80 %
R1 0.510 11.43 %
Current price 0.458
Support S1 0.450 -1.68%
S2 0.440 -3.87%
S3 0.436 -4.74%

FAQ

What is the symbol for Evoke Pharma Stock and on which exchange is it traded?
The symbol for Evoke Pharma is EVOK and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Evoke Pharma Stock?
Evoke Pharma holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

How to buy Evoke Pharma Stock?
Evoke Pharma Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Evoke Pharma Stock.

What's the current price of Evoke Pharma Stock?
As of the end of day on the May 02, 2024, the price of an Evoke Pharma (EVOK) share was $0.458.

What is the 52-week high and low for Evoke Pharma Stock?
The 52-week high for Evoke Pharma Stock is $2.39 and the 52-week low is $0.410.

What is the market capitalization of Evoke Pharma Stock?
As of the May 02, 2024, the market capitalization of Evoke Pharma is 3.88M.

When is the next earnings date for Evoke Pharma?
The upcoming earnings date for Evoke Pharma is May 20, 2024.
Click to get the best stock tips daily for free!

About Evoke Pharma

Evoke Pharma Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It is developing Gimoti, a metoclopramide nasal spray that has completed Phase 3 clinical trials to treat symptoms associated with acute and recurrent diabetic gastroparesis in females. The company markets its products to gastroenterologists, internal medicine ... EVOK Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT